Literature DB >> 33882327

Inflammation and Depression: A Public Health Perspective.

Alexander L Chu1, Matthew Hickman2, Nicholas Steel3, Peter B Jones4, George Davey Smith5, Golam M Khandaker6.   

Abstract

The multifaceted role of low-grade systemic inflammation in depression and physical illnesses like cardiovascular disease highlights complex interactions between the body, brain and mind. While current research on inflammation and depression has largely focused on exploring possible disease mechanisms and therapeutic potential, we seek to broaden the current discussion by introducing a public health perspective. In this Viewpoint, we propose that inflammation and its contributing sources could represent important targets for public health strategies aimed at improving both mental and physical health. We discuss potential universal, selective and indicated primary prevention strategies for inflammation-related depression. We consider potential approaches to secondary prevention, including scope for anti-inflammatory treatment and CRP testing for guiding treatment allocation and prognosis. Preventive strategies discussed here could also be relevant for other inflammation-mediated mental health conditions.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Immunopsychiatry; Inflammation; Mental Health; Prevention; Public Health

Mesh:

Year:  2021        PMID: 33882327     DOI: 10.1016/j.bbi.2021.04.015

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  5 in total

1.  Interaction effect between childhood abuse and interleukin-1β levels on suicidality in depressed patients.

Authors:  Ju-Yeon Lee; Min Jhon; Ju-Wan Kim; Hee-Ju Kang; Sung-Wan Kim; Il-Seon Shin; Hwa Jin Cho; Byeong Jo Chun; Jae-Min Kim
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-25       Impact factor: 5.270

Review 2.  Sarcopenia and nervous system disorders.

Authors:  Jie Yang; Feifei Jiang; Ming Yang; Zhizhi Chen
Journal:  J Neurol       Date:  2022-07-13       Impact factor: 6.682

Review 3.  Utilization of Mind-Body Intervention for Integrative Health Care of COVID-19 Patients and Survivors.

Authors:  Hyun-Jeong Yang; Noriko Setou; Eugene Koh
Journal:  Int J Environ Res Public Health       Date:  2022-05-29       Impact factor: 4.614

4.  Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation.

Authors:  Lili Hu; Jue Wang; Na Wu; Xiaoge Zhao; Donghui Cai
Journal:  PeerJ       Date:  2022-09-23       Impact factor: 3.061

5.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.